Skip to main content

Find Clinical Trials

Home
Conditions
Metastatic Colorectal Cancer With RAS Mutation

Clinical trial condition

Metastatic Colorectal Cancer With RAS Mutation

Explore clinical trials studying Metastatic Colorectal Cancer With RAS Mutation. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Colorectal Cancer With RAS Mutation trial results

Enrolling by Invitation

XS-03 in Combination With FOLFOX or FOLFIRI and Bevacizumab for Treatment of Metastatic Colorectal Cancer Patients With RAS Mutation

NCT06936527

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +10 more
Locations: Beijing Cancer Hospital Beijing, China

View Trial Details